SCHEMBL23366325

SCHEMBL23366325

CCc1conc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.47
PTGS1 P23219 2/20 0.47
GABRA5 P31644 2/20 0.45
HSP90AA1 P07900 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP19A1 P11511 1/20 0.38
NOTUM Q6P988 1/20 0.37
TSHR P16473 2/20 0.37
GAA P10253 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8168464 0.82 CYP19A1 (0.44) PTGS2PTGS1GABRA5HSP90AA1ALDH1A1
SCHEMBL13960573 0.81 CYP2A6 (0.44) KMT2AALDH1A1MAPTKDM4ELMNA
SCHEMBL2929388 0.81 NOTUM (0.49) PTGS2GABRA5HSP90AA1MEN1KMT2A
SCHEMBL8306253 0.81 GABRA5 (0.42) PTGS2PTGS1GABRA5HSP90AA1MEN1
SCHEMBL3213310 0.81 PTGS2 (0.41) PTGS2PTGS1GABRA5HSP90AA1MEN1
SCHEMBL28139688 0.81 NOTUM (0.44) PTGS2PTGS1GABRA5HSP90AA1MEN1
SCHEMBL4973045 0.80 PTGS2 (0.41) PTGS2PTGS1GABRA5HSP90AA1MEN1
SCHEMBL27819710 0.80 KDM4E (0.49) PTGS2PTGS1GABRA5HSP90AA1ALDH1A1
SCHEMBL7372479 0.80 GABRA5 (0.33) PTGS2PTGS1GABRA5HSP90AA1CYP19A1
SCHEMBL5775916 0.78 NOTUM (0.46) PTGS2GABRA5HSP90AA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-05-18 US disclosed
CN-104781271-B Polynucleotides having bioreversible groups 加利福尼亚大学董事会 2018-07-06 CN disclosed
CN-107109405-A Polynucleotide constructs with Bioreversible and abiotic invertibity group 索尔斯蒂斯生物有限公司 2017-08-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues DPYD, DCTD, TYMP PTGS2 3525/4885PTGS1 2771/4885GABRA5 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.